SCHEMBL6602606

SCHEMBL6602606

COC(=O)Nc1ccc(C(=O)N2CCCC(c3ccc(OC)c(OC)c3)=N2)cc1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.55
ALDH1A1 P00352 3/20 0.53
POLB P06746 2/20 0.53
PGR P06401 9/20 0.51
GAA P10253 1/20 0.49
PDE4B Q07343 1/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
MAPT P10636 2/20 0.46
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP3A4 P08684 1/20 0.45
HPGD P15428 1/20 0.45
MAPK10 P53779 1/20 0.45
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6601851 0.93 ALDH1A1 (0.48) MAOBALDH1A1POLBPGRGAA
SCHEMBL6601921 0.92 MAOB (0.57) MAOBALDH1A1POLBPGRGAA
SCHEMBL6605449 0.92 ALDH1A1 (0.48) MAOBALDH1A1POLBPGRGAA
SCHEMBL143053 0.91 MAOB (0.50) MAOBALDH1A1POLBPGRGAA
SCHEMBL6601678 0.91 PDE4B (0.52) MAOBALDH1A1POLBPGRPDE4B
SCHEMBL6603384 0.89 MAOB (0.52) MAOBALDH1A1POLBPGRGAA
SCHEMBL6605929 0.89 ALDH1A1 (0.48) MAOBALDH1A1POLBPGRGAA
SCHEMBL6604558 0.88 MAOB (0.50) MAOBALDH1A1POLBPGRGAA
SCHEMBL6603307 0.88 LMNA (0.54) MAOBALDH1A1POLBPGRGAA
SCHEMBL145108 0.87 ALDH1A1 (0.47) MAOBALDH1A1POLBPGRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 US disclosed